Ítems similars: White Book - Multiple Myeloma: SCB Survey Highlights Growth Potential of New Agents
- White Book - Biotechnology: ASCO 2005 Highlights
- White Book - Orthopaedic Pricing Power, Equipment Choice & Sticky Surgeons
- White Book - Global Biotechnology & Pharmaceuticals: ASCO 2006 Highlights
- Black Book - New Developments In The Operating Room Environment
- White Book - Celgene: An Abundance of Revlimid Opportunities in Myeloma, But Maintenance Is the Biggest Driver
- White Book - AstraZeneca: Dissecting the Potential of Exanta